Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Pfizer Inc. recalls DOBUTamine Injection

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Discoloration; discolored solution from cracked vials
Products
  • DOBUTamine Injection
Where it was sold

Nationwide in the USA

Nationwide

Units affected
98,410 vials
About this recall
DOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL), 20 mL per Single-dose Vial, carton of 10 Fliptop Vials, Rx only, For Intravenous Use Only, Made in Italy, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC Carton: 0409-2344-02; NDC Vial: 0409-2344-62